Many publications have investigated the effect of APOE4 on the degradation of amyloid β (Aβ), the main component of plaques found in the brains of AD patients (Castellano et al., 2011; Deane et al., 2008; Lin et al., 2018). The gene discussed is APOE; the disease is Alzheimer disease.